BGB-45035

N/A

Report date: 2025/08/07 20:00:08
NME

Base Information

Drug NameBGB-45035
Drug Alias NameBGB-45035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 degraders
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsPrurigo NodularisAutoimmune DiseasesDermatitis, Atopic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeOne Medicines Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeOne Medicines LtdBeigene (Suzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisAutoimmune DiseasesDermatitis, Atopic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A